Samsung Biologics at 2025 J.P. Morgan Healthcare Conference

Samsung Biologics Outlines Key Business Achievements and 2025 Outlook at the J.P. Morgan Healthcare Conference Samsung Biologics, a leading global contract development and manufacturing organization (CDMO), recently presented its latest business developments and 2025 outlook at the 43rd annual J.P.…












